Cullinan Oncology, Inc.

NASDAQ

CGEM

Stock

Yield per half year: -1.77%
Dividend yield: 0%
Sector: Healthcare

Compare companies

Download the report:

Excel

Word

PDF

	Cullinan Oncology, Inc.	Gilead Sciences	Amgen
Capitalization
Price	7.76	120.94	291.76
Price priv.
Number of shares, million	53.77	1255	541
Capitalization, billion	0.4108	150.63	154.17
EBITDA, billion	-0.1672	4.43	13.36
EV, billion	0.5741	132.19	188.41
Profit and loss report
Net profit, billion	-0.1674	0.48	4.09
Revenue, bln, billion	0.0189	28.75	33.42
EPS	-3.11	0.3825	7.56
Balance
Assets, bln, billion	0.6218	59	91.84
Debt, bln, billion	0.0022	26.71	60.1
Balance cost, billion	0.5903	19.33	5.88
Cash, bln, billion	0.083	9.99	11.97
Coefficients
Dividend yield, %	0	2.89	3.07
Dividend	0	3.14	9.39
Dividend yield priv., %	0	0	0
Dividend priv.	0	0	0
Dividends/profit, %	0	816.25	118.14
P/S	20.06	4.02	4.2
P/BV	1.11	6	23.87
P/E	-2.45	240.57	34.3
Ev/Ebitda	-3.43	29.81	14.11
Debt/Ebitda	-0.0129	6.02	4.5
Efficiency
ROE	-32.06	2.28	67.55
ROA	-30.27	0.7926	4.33
ROIC	-17.58	11.06	17
Ebitda margin	-884.4	15.42	39.96
Net margin	-358.7	1.67	12.24
Momentum
1 week, price changes	-1.21 %	-0.9509 %	+2.29 %
1 month, price changes	+30.2 %	+7.77 %	-0.0235 %
3 months, price changes	-5.71 %	+5.84 %	+0.5221 %
6 months, price changes	-1.77 %	+15.54 %	+6.12 %
1 year, price changes	-51.83 %	+39.58 %	-8.2 %
3 years, price changes	-37.17 %	+95.99 %	+31.45 %
5 years, price changes		+59.59 %	+25.02 %
10 years, price changes		+117.96 %	+185.69 %

More data >>

Pay for your subscription

More functionality and data for company and portfolio analysis is available by subscription

Subscribe

Shares

Tools

Community

Contacts

2025 © Investing Port
Contacts | Advertising
The use of porti.ru materials is permitted only if there is an active indexed link to the source.